Najib Yamani

Saudi Arabia Draws the Global Future of Stem Cell Transplantation

July 20, 2026 - 00:03 | Last update July 20, 2026 - 00:03

Follow Okaz channel on WhatsApp

When Dr. Majid Al-Fayyad, with the confidence of a seasoned expert, said at the 'Future of Health' summit in Washington that the transformation of the health sector under Saudi Arabia's visionary Vision is cementing its position as a global model for resilient, innovation-based health systems, and that this transformation extends to gene therapy and stem cell fields, where the Kingdom is taking bold steps to establish itself as a leading hub for advanced biologics, he was fully aware and confident in his words, grounded in the Vision's emphasis on owning knowledge before resources, and that the Kingdom is one of the foremost makers of scientific and medical transformation globally, moving beyond its traditional role to produce medical knowledge and create new clinical standards that could reshape global medical practice.

A few days ago, we witnessed a new achievement by King Faisal Specialist Hospital & Research Centre in Jeddah in developing and applying the world's first clinical protocol based on a precise predictive algorithm to estimate the quantity of stem cells expected to be collected from each donor, resulting in unprecedented results in the history of global stem cell transplantation.

With a success rate of 100% in male donors for collecting stem cells from the first session, while the success rate reached 94.9% across all donors, completely eliminating the need for the third and fourth sessions, something previous global protocols could not achieve, this milestone is registered internationally in the name of Saudi Arabia, marking a shift from a trial-and-error approach to a method based on accurate scientific prediction and advance planning, a hallmark of modern medicine where data and algorithms become tools that help the physician make optimal decisions before starting treatment.

True innovation lies not only in developing a treatment protocol but also in building a system reliant on analytical intelligence and predictive algorithms, allowing the physician to know the quantity of cells expected to be collected before the procedure begins with high precision.

Medical decision-making no longer depends solely on clinical experience but is now supported by precise scientific analysis that reduces the margin of error and increases treatment efficiency. This represents a feature of modern medicine, where medical knowledge integrates with data science and artificial intelligence to produce the best therapeutic outcomes.

The impact of this innovation extends to the human dimension, preserving the donor's dignity and enhancing their safety.

For decades, many donors were forced to return multiple times to complete stem cell collection, with the associated physical and mental exhaustion, side effects, and potential hospitalization.

The new Saudi protocol succeeded in reducing this suffering, decreasing the need for repeated collection sessions, lowering doses of stimulation drugs, and minimizing potential complications, making the donation experience safer, more humane, and more efficient.

While the donor is the primary beneficiary, the patient remains the biggest winner from this achievement. Patients with blood cancers and bone marrow diseases are in a race against time; delays in obtaining stem cells can directly affect treatment success chances.

Collecting cells from the first session saves time, accelerates the transplantation process, and gives patients a better chance to receive treatment in a timely manner, which reflects on recovery rates and quality of life.

Under the guidance and direction of visionary Prince Mohammed Al-Khair, the Specialist is no longer just a treatment-providing institution but has become a maker of medical knowledge.

This achievement did not remain within the hospital's walls but was published in the journal Blood Global Hematology, affiliated with the American Society of Hematology, as original scientific research, granting it international scientific value and making its results applicable and evaluable worldwide.

This success extends a long legacy of excellence and leadership in organ transplantation, oncology, genomic medicine, cell therapies, and advanced medical research, and is a direct fruit of the Kingdom's Vision that made scientific research and health innovation a strategic priority, and that investing in people and research centers is the true path to building a knowledge economy.

Today, the Kingdom is moving from importing knowledge to exporting it, offering the world a new clinical protocol, an innovative algorithm, and a therapeutic standard to become an international reference in stem cell transplantation centers.

This is the real transformation: moving from a recipient to a producer, from consuming knowledge to creating it, and from following medical developments to leading them.

What the Specialist in Jeddah achieved is not merely a success for a medical institution but a success for a nation that believed investing in science is the most enduring investment, and that true leadership lies in the rigorous knowledge produced by minds and the innovations that change people's lives, shape the future of medicine, and place the name of the Kingdom at the forefront of countries that produce medical knowledge and contribute to directing its global course.